The study report worldwide Paraganglioma Market covers the market analysis for the regions - North America, Europe, Asia Pacific/ Southeast Asia and Row and country analysis of China, Japan, and India focusing on top manufacturers in world market and the market share they hold including their contribution to the market growth
Pune, India -- (SBWIRE) -- 12/06/2017 -- The Worldwide Paraganglioma Market research report is growing with the rapid pace; mainly due the burgeoning Healthcare Sector. According to a recent study report published by the Market Research Future, The Global Paraganglioma Industry Research report is booming and expected to gain prominence over the forecast period. The Market is forecasted to demonstrate a huge growth by 2023, surpassing its previous growth records in terms of value & volume. Considering all these factors The World Paraganglioma Market is expected to grow at a CAGR of ~6.1 % during the forecast period 2017-2023.
Market Research Future published new report, titled "Paraganglioma Market -Research Report: Global Forecast to 2023".
Key Players in Global Paraganglioma Market:
Some of key the players in the market are Bristol-Myers Squibb Company (U.S.), GlaxoSmithKline Plc. (U.K.), Bayer AG (Germany), Novartis AG (Switzerland), Spectrum Pharmaceuticals Inc. (U.S.), Amgen, Inc. (U.S.), Eli Lilly and Company (U.S.), AstraZeneca Plc. (U.K.), F. Hoffmann-La Roche Ltd. (Switzerland), Janssen Biotech, Inc. (U.S.), AbbVie Inc. (U.S.), Takeda Pharmaceuticals (Japan), Pfizer, Inc. (U.S.), Sanofi (France), Merck & Co., Inc. (U.S.), Immunomedics (U.S.),and Oncomed Pharmaceuticals (U.S.).
A paraganglioma or glomus tumors is a rare type of cancer occurs in a variety of places in the head and neck. The tumor begins in certain nerve cells that are distributed throughout the body. Paragangliomas affect at any age and over half of the paragangliomas appear in the temporal bone. Similar to other types of cancer, paragangliomas is very difficult to diagnose in early stages as the tumor is often slow growing and noncancerous (benign). However, it can invade other/ nearby organ and part of the body, and become cancerous and spread distantly. Though a number of diagnostic and therapeutic treatments are available in the market, none of them are that effective for the treatment and diagnostic. According to the research carried out by Florida Hospital System (2014), 1-2 patient in a million develops paragangliomas. According to cancer research the UK in 2012, globally over 14.1 million of new cancer cases were registered. The treatment for all types of cancer are nearly similar, thus, increasing prevalence of cancer has boosted the development of the new treatments. Increasing number of patients suffering from paragangliomas and continuous advances in the treatment have driven the growth of the market. Additionally, deteriorating lifestyle due to alcoholism and smoking, increasing healthcare expenditure, and increasing government support for research & development have fuelled the market growth. A number of treatment are available in the market, however, nearly all the treatment show some or other adverse effects on the body. Additionally, high cost of the treatment and side effects of the therapy may slow the growth of the market during the forecasted period.
The global paraganglioma market is segmented on the basis of types, treatment, and end users.
On the basis of types, the market is segmented into caroid paraganglioma, cervical paraganglioma, jugular paraganglioma, secretory paraganglioma, temporal paraganglioma, vagal paraganglioma, and others.
On the basis of the treatment, the market is categorized into therapeutic treatment and diagnostic treatment. The therapeutic treatment is further segmented into surgery, embolization, and radiotherapy. The embolization is further categorized into liquid embolic agents, sclerosing agents, particulate embolic agents, and others. The radiotherapy is sub-segmented into external beam radiation therapy, brachytherapy, and unsealed source radiotherapy. The diagnostic treatments are further segmented into CT scans, MRI, angiography, blood test, and others.
On the basis of the end users, the market is segmented into hospital & clinics, ambulatory care centers, and others.
GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/4838 .
The Americas account for the major share of the global paraganglioma market owing to the increasing prevalence of paragangliomas, well-developed technology and increasing government support for research & development. Moreover, high healthcare expenditure and changing lifestyle have fuelled the growth of the Americas paraganglioma market. The concentration of major players in this region is likely to support the growth of the market during the forecasted period.
Europe holds the second largest paraganglioma market, which is followed by Asia Pacific. Availability of the funds for research & development and strong government support have driven the market growth. Asia Pacific is the fastest growing paraganglioma market owing to the increasing prevalence of cancer, rapidly developing the economy and increasing government support.
On the other hand, the Middle East & Africa hold the least share of the market due to poor political conditions in Africa and limited availability of funds and availability of medical facilities. The Middle East dominates the Middle East & Africa Paraganglioma market due to the presence of well-developed countries like Kuwait, Qatar, Oman and South Arabia. Whereas, Africa region is expecting a healthy growth due to the presence of huge opportunity for the development of the market.
Major Table of Contents:
Chapter 1 Report Prologue
Chapter 2 Market Introduction
Chapter 3 Research Methodology
Chapter 4 Market Dynamics
Chapter 5 Market Factor Analysis
Chapter 6 Global Paraganglioma Market, By Types
Chapter 7 Global Paraganglioma Market, By Treatment
Chapter 8 Global Paraganglioma Market, By End User
Chapter 9 Global Paraganglioma Market, By Region
Chapter 10 Company Landscape
Chapter 11 Company Profiles
Chapter 12 MRFR Conclusion
Chapter 13 Appendix
GET DISCOUNT @ https://www.marketresearchfuture.com/check-discount/4838 .
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
+1 646 845 9312